Found: 43
Select item for more details and to access through your institution.
Dosing of IV posaconazole to treat critically ill patients with invasive pulmonary aspergillosis: a population pharmacokinetics modelling and simulation study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 7, p. 1645, doi. 10.1093/jac/dkae160
- By:
- Publication type:
- Article
Do we perceive sensations inside and outside of our body differently? Perceptual, emotional, and behavioral differences between visceral and somatic sensation, discomfort, and pain.
- Published in:
- Neurogastroenterology & Motility, 2024, v. 36, n. 6, p. 1, doi. 10.1111/nmo.14787
- By:
- Publication type:
- Article
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 5, p. 645, doi. 10.1007/s40262-024-01361-8
- By:
- Publication type:
- Article
Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across Europe.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2024, v. 134, n. 4, p. 556, doi. 10.1111/bcpt.13983
- By:
- Publication type:
- Article
Agreement Between a Colorimetric Assay and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry for Quantifying Paracetamol Plasma Concentrations.
- Published in:
- AAPS Journal, 2024, v. 26, n. 1, p. 1, doi. 10.1208/s12248-024-00890-1
- By:
- Publication type:
- Article
TRPA1 Antagonist LY3526318 Inhibits the Cinnamaldehyde‐Evoked Dermal Blood Flow Increase: Translational Proof of Pharmacology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 5, p. 1093, doi. 10.1002/cpt.3024
- By:
- Publication type:
- Article
Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 7, p. 1085, doi. 10.3390/antibiotics12071085
- By:
- Publication type:
- Article
Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 7, p. 1792, doi. 10.3390/pharmaceutics15071792
- By:
- Publication type:
- Article
A Model-Based Tool for Guiding Infliximab Induction Dosing to Maximize Long-term Deep Remission in Children with Inflammatory Bowel Diseases.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 6, p. 896, doi. 10.1093/ecco-jcc/jjad009
- By:
- Publication type:
- Article
Insights into the Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Older Adults with Atrial Fibrillation: A Structured Narrative Review.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 3, p. 351, doi. 10.1007/s40262-023-01222-w
- By:
- Publication type:
- Article
Liposomal amphotericin B exposure in critically ill patients: a prospective pharmacokinetic study.
- Published in:
- Medical Mycology, 2022, v. 60, n. 10, p. 1, doi. 10.1093/mmy/myac074
- By:
- Publication type:
- Article
Ceftriaxone dosing based on the predicted probability of augmented renal clearance in critically ill patients with pneumonia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Multi‐model averaging improves the performance of model‐guided infliximab dosing in patients with inflammatory bowel diseases.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 8, p. 1045, doi. 10.1002/psp4.12813
- By:
- Publication type:
- Article
Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis.
- Published in:
- Clinical & Experimental Dermatology, 2022, v. 47, n. 7, p. 1324, doi. 10.1111/ced.15157
- By:
- Publication type:
- Article
Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 7, p. 1059, doi. 10.1093/ecco-jcc/jjac009
- By:
- Publication type:
- Article
Systematic Comparison of Hospital-Wide Standard and Model-Based Therapeutic Drug Monitoring of Vancomycin in Adults.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 7, p. N.PAG, doi. 10.3390/pharmaceutics14071459
- By:
- Publication type:
- Article
Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.892534
- By:
- Publication type:
- Article
The TARGET trial as a plea for model-informed precision dosing of piperacillin/tazobactam in patients with sepsis.
- Published in:
- Intensive Care Medicine, 2022, v. 48, n. 6, p. 768, doi. 10.1007/s00134-022-06679-0
- By:
- Publication type:
- Article
Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA‐FLU study.
- Published in:
- Mycoses, 2022, v. 65, n. 6, p. 656, doi. 10.1111/myc.13446
- By:
- Publication type:
- Article
Editorial: Therapeutic Drug Monitoring (TDM): A Useful Tool for Pediatric Pharmacology Applied to Routine Clinical Practice.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.931843
- By:
- Publication type:
- Article
New Tools for Therapeutic Drug Monitoring: Making Big Things out of Small Pieces.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 2, p. 175, doi. 10.1093/ecco-jcc/jjab137
- By:
- Publication type:
- Article
Population pharmacokinetic‐pharmacodynamic model‐based exploration of alternative ustekinumab dosage regimens for patients with Crohn's disease.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 323, doi. 10.1111/bcp.14971
- By:
- Publication type:
- Article
Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal Function.
- Published in:
- Infection & Drug Resistance, 2022, v. 15, p. 53, doi. 10.2147/IDR.S343264
- By:
- Publication type:
- Article
Population pharmacokinetics of cefazolin in maternal and umbilical cord plasma, and simulated exposure in term neonates.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseases.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 10, p. 3776, doi. 10.1111/bcp.14785
- By:
- Publication type:
- Article
Ustekinumab Dosing Individualization in Crohn's Disease Guided by a Population Pharmacokinetic–Pharmacodynamic Model.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 10, p. 1587, doi. 10.3390/pharmaceutics13101587
- By:
- Publication type:
- Article
Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 10, p. 1623, doi. 10.3390/pharmaceutics13101623
- By:
- Publication type:
- Article
Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokinetics.
- Published in:
- Mycoses, 2021, v. 64, n. 9, p. 1111, doi. 10.1111/myc.13300
- By:
- Publication type:
- Article
Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients Are Not Affected by Extracorporeal Membrane Oxygenation: A Matched Cohort Analysis.
- Published in:
- Microorganisms, 2021, v. 9, n. 6, p. 1310, doi. 10.3390/microorganisms9061310
- By:
- Publication type:
- Article
Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort Study.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 5, p. 557, doi. 10.3390/antibiotics10050557
- By:
- Publication type:
- Article
Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Modelling of the relationship between infliximab exposure, faecal calprotectin and endoscopic remission in patients with Crohn's disease.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 1, p. 106, doi. 10.1111/bcp.14364
- By:
- Publication type:
- Article
Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00894
- By:
- Publication type:
- Article
Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs?
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00620
- By:
- Publication type:
- Article
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD Patients.
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 3, p. 332, doi. 10.1093/ecco-jcc/jjz151
- By:
- Publication type:
- Article
Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 10, p. 1248, doi. 10.1093/ecco-jcc/jjz050
- By:
- Publication type:
- Article
Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 7, p. 864, doi. 10.1093/ecco-jcc/jjz008
- By:
- Publication type:
- Article
Optimising infliximab induction dosing for patients with ulcerative colitis.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 4, p. 782, doi. 10.1111/bcp.13859
- By:
- Publication type:
- Article
Letter: overcoming secondary loss of response to infliximab—it is not the drug, it is how you use it! Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 9, p. 1029, doi. 10.1111/apt.14974
- By:
- Publication type:
- Article
Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 11, p. 1316, doi. 10.1093/ecco-jcc/jjy111
- By:
- Publication type:
- Article
Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 101, doi. 10.2147/CPAA.S138414
- By:
- Publication type:
- Article
Blocking α<sub>4</sub> β<sub>7</sub> Integrin Through Vedolizumab: Necessary but not Sufficient?
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 8, p. 903, doi. 10.1093/ecco-jcc/jjx033
- By:
- Publication type:
- Article
Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2016, v. 10, n. 5, p. 575, doi. 10.1093/ecco-jcc/jjv241
- By:
- Publication type:
- Article